Sort
78,016 grants matching “breast cancer”
Role of the Follicle-Depleted Ovary in the Pathogenesis of Chronic Diseases
$537,252Jay R Kaplan · Wake Forest University Health Sciences · R01 · FY2007 · AG
Vaginal Tactile Imager for Pelvic Floor Biomechanical Assessment
$537,249Vladimir Egorov · Artann Laboratories, Inc. · R44 · FY2012 · AG
Mechanisms of Normal Tissue Toxicity
$537,232Deborah Citrin · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Revisiting Prior Cancer as an Exclusion Criterion for Cancer Clinical Trials
$537,213Sandi Leigh Pruitt · Ut Southwestern Medical Center · R01 · FY2019 · CA
Translation of In-Clinic Gains to Gains in Daily Life
$537,211Catherine E Lang · Washington University · R37 · FY2025 · HD
TARGETING THE IMMUNE SYSTEN;S NATURAL RESPONSE TO CELL DEATH TO IMPROVE THERAPEUTIC RESPONSE IN BREAST CANCER
$537,177Vanderbilt University, The · · FY2013 · Department of the Army
Transdermal Nitroglycerin Therapy for Menopausal Hot Flashes
$537,166Alison Huang · University Of California, San Francisco · R01 · FY2019 · AG
A platform to functionally sort and analyze tumor cells within combinatorial metastatic micorenvironments
$537,134David Kevin Wood · University Of Minnesota · R01 · FY2024 · CA
The Role of Fgf Signaling in Vertebrate Development
$537,106Mark B Lewandoski · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
The Role of Pdcd4 in Translation, Tumorigenesis and Tumor Progression
$537,100Nancy H. Colburn · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Rural Breast Cancer Survivors Intervention
$537,089Karen Meneses · University Of Alabama At Birmingham · R01 · FY2010 · CA
Mechanisms of mutant p53 reactivation
$537,081Peter Kaiser · University Of California-Irvine · R01 · FY2024 · CA
Effectiveness of Pre-Operative MRI in Breast Cancer Surgery and Outcomes
$537,020Tracy Onega · Dartmouth College · R01 · FY2014 · CA
HUMAN STRINGENT RESPONSE AS NOVEL THERAPEUTIC APPROACHES FOR BREAST CANCERS
$537,012Duke University · · FY2015 · Department of the Army
Validation and translation of a non-invasive, MR-guided breast cancer therapy
$536,994Allison Payne · University Of Utah · R37 · FY2022 · CA
Validation and translation of a non-invasive, MR-guided breast cancer therapy
$536,994Allison Payne · University Of Utah · R37 · FY2021 · CA
Targeting dynamic palmitoylation of TEAD transcription factors
$536,986Xu Wu · Massachusetts General Hospital · R01 · FY2023 · CA
Targeting dynamic palmitoylation of TEAD transcription factors
$536,984Xu Wu · Massachusetts General Hospital · R01 · FY2022 · CA
Development of Magnetic Resonance Fingerprinting (MRF) to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer
$536,972Yong Chen · Case Western Reserve University · R01 · FY2024 · CA
Tumor Microenvironment in Cancer Progression
$536,966Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Delineating Functional Immunity via Image-Guided PET
$536,875Nerissa Therese Viola · Wayne State University · R37 · FY2022 · CA
New and integrated perspectives on modification of tamoxifen effectiveness
$536,872Timothy L Lash · Emory University · R01 · FY2015 · CA
Targeting myeloid suppression to enhance anti-tumor immunity in breast cancer
$536,866Evanthia Theodosiou Roussos Torres · University Of Southern California · R01 · FY2024 · CA
Multiparameter single-cell genomics platform for personalized treatment of cancer
$536,852Eric Brouzes · State University New York Stony Brook · R01 · FY2018 · CA
Genes for human chronic pain syndromes through whole genome sequencing
$536,823Jeffrey R Gulcher · Decode Genetics, Ehf · R01 · FY2012 · DE